MarketInOut Stock Screener Log In | Sign Up

Veradermics Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Veradermics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization6,009.24 mln
Float29.86 mln
Earnings Date11/30/2026

1-Year Forecast

170.50
Attractive

Relative Strength

99 / 100
Top performer

Debt / Equity

0.00
Debt-free

ROE

-16.11
Negative

ROA

-15.79
Deeply negative

Business Description

Veradermics is a New Haven, Connecticut-based medical company founded in 2019 that creates new treatments for skin and hair conditions in both adults and children. Its pipeline includes an oral non-hormonal pill for chronic hair loss, a dissolving patch that delivers immunotherapy for common warts, and targeted therapies for alopecia areata and molluscum contagiosum. The company works closely with dermatologists, clinicians, and medical researchers to bring these solutions to patients.

Key Fundamentals

EPS-4.24
ROE-16.11
ROIC-1,026
ROA-15.79
Interest Cover-193
EBITDA, mln-72.05
EV / EBITDA-70.23
EV / EBIT-70.23

Quote Details

Last 139.69
Change -4.16 (-2.89%)
Open 141.79
Volume 464,760
Turnover 64,922,324
Average Volume 832,135

Financial Ratios

Leverage Ratio1.01
Current Ratio70.53
Price / Book7.22
Price / Tangible Book7.22
Debt / Equity0.00

Financial Strength

1-Year Target Price170.50
Short Ratio3.92
Short % of Float13.59

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.66% 60 / 100   
1 Month 19.17% 97 / 100   
2 Months 25.37% 96 / 100   
6 Months 38.31% 96 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog